Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter

Your Filters

Publisher : wiley-blackwell Subject : covid-19 Subject : emotional engagement Subject : immunization, secondary
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients.

  • Authors : Shem-Tov N; Division of Hematology and Bone-Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Subjects: Hematopoietic Stem Cell Transplantation* ; Immunogenicity, Vaccine*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. 884-891. Date of Electronic Publication: 2021 Oct 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece.

  • Authors : Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Karalis V

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Antibodies, Neutralizing

  • Source: American journal of hematology [Am J Hematol] 2022 Apr; Vol. 97 (4), pp. E147-E150. Date of Electronic Publication: 2022 Jan 25.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Editorial & Opinion

Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.

Subjects: BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*therapeutic use ; COVID-19/COVID-19/COVID-19/*prevention & control; Adult

  • Source: British journal of haematology [Br J Haematol] 2022 Mar; Vol. 196 (5), pp. e38-e40. Date of Electronic Publication: 2021 Oct 20.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/drug therapy

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. 548-558. Date of Electronic Publication: 2021 Oct 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.

  • Authors : Chan WY; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.; Research Department of Haematology, UCL Cancer Institute, London, UK.

Subjects: Vaccination*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (3), pp. e21-e26. Date of Electronic Publication: 2021 Oct 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients.

  • Authors : Attolico I; Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.; Tarantini F

Subjects: Hematopoietic Stem Cell Transplantation*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*therapeutic use ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. 928-931. Date of Electronic Publication: 2021 Oct 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study.

  • Authors : Rottenstreich M; Department of Obstetrics & Gynecology, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2022 Jan; Vol. 129 (2), pp. 248-255. Date of Electronic Publication: 2021 Oct 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100935741 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Editorial & Opinion

Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine.

  • Authors : Chai Q; Department of Paediatrics and Adolescent Medicine, Regionshospital Nordjylland, Hjoerring, Denmark.; Nygaard U

Subjects: BNT162 Vaccine* ; COVID-19*; Adolescent

  • Source: Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2022 Jan; Vol. 111 (1), pp. 125-127. Date of Electronic Publication: 2021 Oct 28.Publisher: Wiley-Blackwell Country of Publication: Norway NLM ID: 9205968 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.

Subjects: Immunotherapy, Adoptive*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*biosynthesis ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

  • Source: British journal of haematology [Br J Haematol] 2022 Jan; Vol. 196 (2), pp. 360-362. Date of Electronic Publication: 2021 Sep 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.

  • Authors : Crickx E; Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.; Moulis G

Subjects: BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*adverse effects ; COVID-19/COVID-19/COVID-19/*complications ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: British journal of haematology [Br J Haematol] 2021 Dec; Vol. 195 (5), pp. 703-705. Date of Electronic Publication: 2021 Aug 31.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×